The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort. (Q53521312)

15 May 2018

title

The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort. (English)

1 reference

15 May 2018

1 reference

5

Shumaker SA

1 reference

15 May 2018

author name string

Herrington DM

1

1 reference

15 May 2018

Reboussin DM

2

1 reference

15 May 2018

Klein KP

3

1 reference

15 May 2018

Sharp PC

4

1 reference

15 May 2018

Snyder TE

6

1 reference

15 May 2018

Geisinger KR

7

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 June 2000

1 reference

15 May 2018

Contemporary Clinical Trials

published in

1 reference

15 May 2018

volume

21

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

257-285

1 reference

15 May 2018

Epidemic of cardiovascular disease and stroke: the three main challenges. Presented at the 71st scientific sessions of the American Heart Association. Dallas, Texas

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

A prospective study of postmenopausal estrogen therapy and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Use of replacement estrogens and the risk of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

The epidemiology of cardiovascular disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Risk/benefit considerations of antiestrogen/estrogen therapy in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Restricted Randomization Designs in Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Coronary artery quantitation and data management system for paired cineangiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Reproducibility and validity of a semiquantitative food frequency questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Vitamin E consumption and the risk of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Vitamin E consumption and the risk of coronary disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Gender, coronary artery disease, and coronary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

The MOS social support survey

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Prognostic significance of progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Coronary angiography: more than meets the eye

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Oestrogens Attenuate Abnormal Coronary Vasoreactivity in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

The protective effects of estrogen on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2800%2900054-4

7 January 2021

10.1016/S0197-2456(00)00054-4

Identifiers

DOI

1 reference

15 May 2018

release_nehc3pglsnarrdnu33pmb6dwvm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nehc3pglsnarrdnu33pmb6dwvm

24 November 2022

mapped directly with Wikidata item

PubMed ID

10822123

1 reference

15 May 2018